NUWE - nuwellis.com PEG Multiple

Symbol and logo of brand nuwellis.com (NUWE)

Analyzing the P/E to medium-term growth ratio on GURU.Markets, it is evident that the current figure is 0.00. Nuwellis, Inc. (NUWE) operates within a neutral US geopolitical environment, protected by humanitarian norms. The company develops AI-controlled Aquapheresis systems for heart failure therapy. Business stability is underpinned by its own US-based manufacturing and the widespread implementation of its equipment across clinics.

NUWE - CHF Solutions PEG Multiple over the range 07/04/2022 - 11/15/2026

Nuwellis (NUWE) - metric breakdowns and financial figures

- current quotes and average value forecast:
Fundamental company analysis:NUWE (CHF Solutions)
Original product of nuwellis.com

Nuwellis, Inc. (NUWE) achieves scalability through high-margin supplies of consumables for ultrafiltration systems, creating a steady cash flow. By analyzing the historical PEG ratio, an investor compares the current P/E market multiple with net income growth rates: a value below one signals a fundamental undervaluation of the asset relative to its expansion, confirming the potential for business value growth.

Competing companies

DXCM - Price to Earnings Adjusted for Growth Rate|Penumbra Corp - Price/Earnings to Growth Multiple|PEG Multiple Novanta NOVT|Haemonetics Corp - PEG Multiple|Inspire Medical Systems, Inc. - Company Value to Earnings Growth Ratio|PRCT: PEG Multiple|CNMD - Growth-Adjusted Market Cap to Net Income|PLSE (pulsebiosciences.com) - PEG Multiple|Price/Earnings to Growth Multiple InMode (INMD)|Price/Earnings to Growth Ratio Picard Medical Corp (PMI)|SRDX (Surmodics Inc) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Senseonics Holdings SENS|NPCE - Price/Earnings to Growth Multiple|Tactile Systems Technology Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate Sanuwave Health Inc|OM: PEG Multiple|Growth-Adjusted P/E Ratio ELMD|LNSR (LENSAR Inc) - PEG Multiple|AVITA Medical, Inc (RCEL) - Growth-Adjusted Market Cap to Net Income|PEG Multiple PROF|Price/Earnings to Growth Multiple Baird Medical BDMD|PEG Multiple EDAP (EDAP TMS SA)|PEG Multiple Apyx Medical APYX|ICCM - Price/Earnings to Growth Ratio|LUNG: Price/Earnings to Growth Ratio|TELA (TELA Bio Corp) - Price/Earnings to Growth Multiple|CytoSorbents Corp - Growth-Adjusted Payback Ratio|SRTS (Sensus) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Zynex Medical ZYXI|Price/Earnings to Growth Ratio electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Price to Net Income Growth Ratio|Inspira Technologies Oxy B.H.N. Ltd. - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income seastarmedical.com (ICU)|IRIDEX Corp - PEG Multiple|Growth-Adjusted Market Cap to Net Income Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio PFSA (Profusa, Inc)|Price/Earnings to Growth Ratio strataskinsciences.com|Price/Earnings to Growth Multiple GlucoTrack, Inc. (GCTK)|PEG Multiple NAOV|VERO - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Aethlon Medical AEMD|ASXC: Growth-Adjusted P/E Ratio|AVGR: Price/Earnings to Growth Multiple|BioSig Technologies, Inc. - Company Value to Earnings Growth Ratio|CUTR: PEG Multiple|Growth-Adjusted P/E Ratio KNW|Price/Earnings to Growth Ratio Inari Medical, Inc.|Price to Earnings Adjusted for Growth Rate Nevro Corp. NVRO|Price/Earnings to Growth Ratio ReShape Lifesciences Inc (RSLS)|Price/Earnings to Growth Ratio SILK (silkroadmed.com)